Christina Bessant Cameron

Canadian Life Science Capital Markets Investor. Working momma of three and an avid hockey player and golfer.

[Christina Bessant Cameron @Chrislcameron]

2025 reminded me what disciplined capital markets strategy and execution can deliver!
⭐ $EPRX: ~+150–170%
⭐ $NPTH.v: ~+180–200%
⭐ $CNVI.v: ~+25–30% + $20M US raise
⭐ $LIB.v (personal): ~+700%+

Fantastic returns. Upside just begun at NPTH.v @ConaviMed! Let's go 2026!

[Select Water Solutions @selectwaterinc]

Proud to celebrate this moment with @LibertyStreamIP — the first tonne of battery-grade lithium carbonate produced under our Permian Basin agreement. A milestone for the project and a step forward for American mineral independence. 🇺🇸

[Investor Breakout @investorbrkt]

One in four Canadians lives with chronic pain, yet hospital wait times can stretch into years.

@NeuPathHealth (TSXV: $NPTH) is addressing that gap by delivering hospital-level treatment within weeks through regulated community clinics.

What stood out to investors at AlphaNorth 2026 was not just demand, but scalability. As its clinic network expands and profitability improves, the company is evolving into a healthcare platform positioned for sustained growth within Canada’s public healthcare framework.

Watch the full Weekly Insight to hear @RyanIverson_ explain why NeuPath earned a Top Five ranking and what other signals are emerging across markets: https://t.co/0FF9fFkpqQ
__
Presented by @MarketOneMedia & @CapitalEvent

@FarhanLalani @NCurrie

#Healthcare #HealthTech #MedicalCare #Investing #Markets

Please see our disclaimer: https://t.co/uXaN48lumn

[Martin Gagel @RadiusResearch]

📋 Upcoming Earnings Webinar | @NeuPathHealth (TSXV: $NPTH)

Join CEO Stephen Lemieux and CFO Jeff Zygouras as they review #NeuPath's Q1 2026 financial results and take live questions from analysts and investors.

Reserve your spot here ➡️ https://t.co/t09wzo7p5Y

#NeuPathHealth #Healthcare #ChronicPain #SportsMedicine #HealthcareServices #MedicalServices

[Joe @Gantosj]

Roberto Bellini $BLU Bellus CEO before selling to $GSK is one of the panelists at #BBHIC2026

Nice to meet Roberto again. Bellus was one of my & $chimeraresearch subs best investment😱, riding from $0.37 to sell at C$17 to GSK 🍻🍸🙏🏻

[Conavi Medical @ConaviMed]

$CNVI.V $CNVIF

#Conavi is thrilled to announce FDA #510k clearance of our next-generation hybrid imaging system and to begin executing on our U.S. commercial launch for H2 2026.

As the first co-registered, co-aligned #IVUS and #OCT platform, our system helps give physicians a more complete view of the vessel, streamline workflows, and enhance precision across one of the most common procedures globally.

With clinical evidence and guideline support strengthening, this represents a significant opportunity in the rapidly expanding #IntravascularImaging market.

Thank you to the #CNVI team, partners, physicians, and investors who made this possible! 🫀🌏

Full Release 🔗 https://t.co/dXVOvkAKjl

[Conavi Medical @ConaviMed]

$CNVI $CNVIF

On #WorldHealthDay, we join @WHO to #StandWithScience! 🧡🌎

Behind the 4M+ #PCI's performed each year, is a parent, spouse, friend, and a physician turning evidence into action to save lives.

#Conavi believes powerful health decisions start with clarity and advance without compromise.

This is why we’re combining #IVUS with #OCT to remove potential blind spots with single modality #IntravascularImaging systems. 🩺

[Conavi Medical @ConaviMed]

$CNVI.V $CNVIF
It’s the season for springing into our next-gen imaging! 🌱

On the Empowered Patient Podcast, #Conavi CEO @ThomasLooby discussed how we're leveraging #AI in our #hybridimaging to drive stronger algorithms, automated insights, and less guesswork for cardiologists. 🫀

Listen here 🎧 https://t.co/leOh7AMiND

[Conavi Medical @ConaviMed]

$CNVI.V $CNVIF

A @EuroInterventio analysis of 350,000+ coronary procedures in Japan’s National Database, shows how imaging-guided PCI is:

➡️ Delivering significantly better outcomes for ACS patients
➡️ Driving a fundamental shift in how interventions are performed
➡️ Demonstrating how #IVUS & #OCT reveals what the other cannot

Providing physicians with the ability to leverage strengths of both modalities during the same procedure is what #ConaviMedical feels is an important step forward in #InterventionalCardiology. 🫀

Details 🔗 https://t.co/xvHhkiVw6E

[Investor Breakout @investorbrkt]

.@NeuPathHealth (TSXV: $NPTH) was named a Top Five Pick at the 2026 AlphaNorth Capital Event for scaling public pain care through community-based medical facilities operating inside Canada’s public healthcare system.

With 12 locations across Ontario and Alberta and rising clinic utilization, the company is growing a provincially reimbursed platform within a system where demand continues to exceed capacity.

Why it drew investor attention:
• $65 million in revenue for the first nine months in 2025, with $5 million in adjusted EBITDA, marking the 27th consecutive quarter of positive adjusted EBITDA
• Preliminary 2025 revenue guidance of $86–$88 million, supported by rising clinic utilization and a National Bank facility funding organic growth and selective acquisitions

Discover the next chapter of NeuPath Health's growth by subscribing to the @investorbrkt newsletter: https://t.co/ePYCtY7y53
__
Presented by @marketonemedia & @CapitalEvent

@FarhanLalani @NCurrie @RyanIverson_

#Healthcare #HealthTech #MedicalCare #Investing #Stocks

Please see our disclaimer: https://t.co/uXaN48m2bV

[Christina Bessant Cameron @Chrislcameron]

https://t.co/KVTb43ddA1

[Conavi Medical @ConaviMed]

$CNVI.V $CNVIF

Every heartbeat reminds us why we do what we do at #ConaviMedical.

This #HeartMonth, we celebrate the researchers and engineers advancing cardiac care, the physicians guiding complex procedures, and the patients whose lives are shaped by better outcomes.

When your most vital organ is on the line, precision matters more than ever. 🫀

[Joe @Gantosj]

$VLTLF $LIB.v 🚀 Bottom Line:
Why This is a Win for us Shareholders
1️⃣ Strategic alignment: HQ in Dallas = faster execution for lithium commercialization.
2️⃣ Upside potential: U.S. listing + DoE grants = funding for growth.
3️⃣ First-mover advantage: LibertyStream is leading Texas #lithium production, a blue ocean market.
4️⃣ ESG tailwinds: Supports U.S. energy security and clean tech goals.

Catalysts to watch for:
✅ Shareholder vote outcome (Mar 2026).
✅ Nasdaq uplisting timeline (late 2026/early 2027).
✅ Commercial production updates (Q4 2026).

Risk? Execution, but the strategy is clear, and the team is doubling down in Texas.

[Conavi Medical @ConaviMed]

$CNVI.V $CNVIF

#Conavi closed it's $12M public offering!

Proceeds are intended to be used toward obtaining FDA #510k clearance for next-gen #Novasight, initiating a targeted market release in the U.S., and supporting general corporate activities.

Big thanks to Bloom Burton Securities and to all the U.S. strategic healthcare investors who participated.

🔗Read more: https://t.co/trhR0WwL9i

[Christina Bessant Cameron @Chrislcameron]

@BobbyKKraft @PlanetMicroCap Happy new year!

[Conavi Medical @ConaviMed]

$CNVI.V $CNVIF

A key moment in this chat with @RadiusResearch reflects on our insights from #TCT2025!

The adoption of #IntravascularImaging is accelerating globally and is increasingly recognized as an essential tool in #PCI's, supporting physicians with enhanced visualization and informed clinical decision-making. 🫀

This captures the energy and momentum driving the next phase of #Conavi's next-gen #Novasight journey.

🔗https://t.co/mrtzqUp1gs

[Christina Bessant Cameron @Chrislcameron]

@Pharmdca $eprx 107%

[Eupraxia Pharmaceuticals @EupraxiaPharma]

$EPRX Q3 financial results & business update.

Thanks to our team, partners & investors for the continued support as we advance our pipeline! 🩺

Full #Eupraxia release 🔗 https://t.co/t3ppg6S5Bq

#Biotech #EoE #DrugDelivery #PrecisionMatters #NASDAQ #TSX #EPRX

[Conavi Medical @ConaviMed]

$CNVI.V $CNVIF

#Conavi has entered into an agreement with the Province of Ontario as part of the Life Sciences Scale-Up Fund (#LSSUF) to support the commercial launch of our next-gen #NovasightHybrid™ system!🫀

We appreciate the @ONeconomy and @VictorFedeli for advancing innovation in #LifeSciences and #MedTech.

🔗 Read the full #CNVI release: https://t.co/TLYIUT7Vqo

[Conavi Medical @ConaviMed]

#ThrowbackThursday ⏪

We're heading back to the @TCTConference in San Francisco, Oct 25–28.

#Conavi is ready for another great week of reconnecting and collaborating with leaders shaping the future of #InterventionalCardiology. 🩺

More @crfheart #TCT2025 details to come!

🔗 https://t.co/7GTFg9TUC7